Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial

Project: Funded research › FWF - Austrian Science Fund

Project Details

Description

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial
StatusActive
Effective start/end date21.08.2024 → 20.08.2027

Fields of science

  • 302024 Haematology
  • 302055 Oncology